IL10 and colitis: In line with this, our findings indicated that taVNS significantly suppressed both local and systemic DSS-induced colitis-associated inflammation by decreasing the levels of inflammatory cytokines, chemokines, and neutrophil/macrophage-related markers while increasing protective anti-inflammatory cytokines such as IL-10 and TGF-β.